The first AVEO Pharmaceuticals trade was made in Q2 2013.
Since then Ken Griffin bought shares 41 more times and sold shares on 36 occasions. The investor completely sold their stake between Q1 2023 and Q1 2023.
Avg closing price
Price range
Sold -315 Thousand shares
Q1 2023
Avg closing price
$14.96
Price range
$14.93
-
$15.00
Increased shares by 673.2% (+275 Thousand shares)
Q4 2022
Avg closing price
$13.85
Price range
$8.48
-
$14.97
New holding (+40.8 Thousand shares)
Q3 2022
Avg closing price
$7.68
Price range
$6.61
-
$8.72
Sold -112 Thousand shares
Q1 2022
Avg closing price
$4.12
Price range
$3.15
-
$6.01
Increased shares by 134.8% (+64.5 Thousand shares)
Q4 2021
Avg closing price
$6.20
Price range
$4.69
-
$7.40
New holding (+47.9 Thousand shares)
Q3 2021
Avg closing price
$5.98
Price range
$5.12
-
$6.89
Sold -32 Thousand shares
Q2 2021
Avg closing price
$6.89
Price range
$6.21
-
$7.45
Sold 17.9% shares (-6.96 Thousand shares)
Q1 2021
Avg closing price
$8.63
Price range
$5.97
-
$15.28
Sold 90.3% shares (-361 Thousand shares)
Q3 2020
Avg closing price
$4.95
Price range
$4.16
-
$6.26
Increased shares by 2356.6% (+384 Thousand shares)
Q2 2020
Avg closing price
$6.31
Price range
$3.47
-
$9.99
Increased shares by 9.5% (+1.41 Thousand shares)
Q1 2020
Avg closing price
$4.96
Price range
$2.60
-
$6.86
Increased shares by 183.4% (+9.62 Thousand shares)
Q4 2019
Avg closing price
$7.36
Price range
$5.10
-
$9.50
New holding (+5.25 Thousand shares)
Q3 2019
Avg closing price
$7.44
Price range
$6.18
-
$10.50
Sold -20.3 Thousand shares
Q2 2019
Avg closing price
$8.57
Price range
$6.60
-
$15.80
Increased shares by 25.8% (+4.16 Thousand shares)
Q1 2019
Avg closing price
$10.32
Price range
$5.11
-
$21.20
Sold 64.9% shares (-29.9 Thousand shares)
Q4 2018
Avg closing price
$22.00
Price range
$14.90
-
$29.80
Increased shares by 925.9% (+41.6 Thousand shares)
Q3 2018